AnaptysBio, Inc (ANAB) stock
ANABNasdaqPharmaceutical PreparationsFiscal year ends June 30
$49.24+2.63 (+5.64%)
Close on Oct 19, 2026Market cap $2.28BP/E –Yield –
AnaptysBio pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
AnaptysBio's pe ratio was 7.5× on Oct 19, 2026.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Oct 19, 2026 | 7.5× | −61.3 |
| 2022 | Jan 31, 2022 | 68.8× | −6.0 |
| 2021 | Dec 31, 2021 | 74.7× | – |
See a number that looks wrong?